WallStreetZenWallStreetZen

NYSE: EBS
Emergent Biosolutions Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Emergent Biosolutions earnings were $75.9M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest EBS earnings report on Sep 30, 2025 announced Q3 2025 earnings of $51.2M, down 526.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, EBS reported annual earnings of -$190.6M, with -74.9% growth. The next EBS earnings date is Mar 10, 2026.

EBS past earnings growth

How has EBS's earnings growth performed historically?

Company
N/A
Industry
-3.07%
Market
55.2%
EBS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
EBS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

EBS earnings history

Current Revenue
$788.9M
Current Earnings
$75.9M
Current Profit Margin
9.6%
EBS's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

EBS Return on Equity

Current Company
14.1%
Current Industry
15%
Current Market
35.1%
EBS's Return on Equity (14.1%)... subscribe to Premium to read more.
High Return on Equity Performance

EBS Return on Assets

Current Company
5.3%
Current Industry
5.6%
EBS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when EBS announces earnings.

EBS Return on Capital Employed

Current Company
12.48%
Current Industry
9.7%
EBS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

EBS vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
EBS$263.60M$75.90M-14.89%$1.42
ORGO$18.04M-$13.39MN/A-$0.12
AQST-$51.38M-$68.98MN/A-$0.71
BIOA-$74.56M-$75.79MN/A$13.61
SIGA$97.47M$74.47M+21.06%$1.04
View Top Pharmaceutical Stocks

EBS earnings dates

Next earnings date
Mar 10, 2026

Emergent Biosolutions Earnings Reports & History FAQ

What were Emergent Biosolutions's earnings last quarter?

On EBS's earnings call on Invalid Date, Emergent Biosolutions (NYSE: EBS) reported Q3 2025 earnings per share (EPS) of $0.96, up 55.56% year over year. Total EBS earnings for the quarter were $51.20 million. In the same quarter last year, Emergent Biosolutions's earnings per share (EPS) was $2.16.

If you're new to stock investing, here's how to buy Emergent Biosolutions stock.

When does Emergent Biosolutions report earnings?

The next EBS earnings date is Invalid Date. Add EBS to your watchlist to be reminded of Emergent Biosolutions's next earnings date.

Is Emergent Biosolutions profitable or losing money?

As of the last Emergent Biosolutions earnings report, Emergent Biosolutions is currently profitable. Emergent Biosolutions's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $75.90 million, a 136.35% decrease year over year.

What was EBS's earnings growth in the past year?

As of Emergent Biosolutions's earnings date in Invalid Date, Emergent Biosolutions's earnings has grown year over year. EBS earnings in the past year totalled $75.90 million.

What are Emergent Biosolutions's earnings expectations?

The current EPS estimate for Emergent Biosolutions's earnings report in Invalid Date is $0.43.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.